Botulinum Toxin Research Associates (Botulinum Toxin Patent Portfolio) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
Botulinum Toxin Research Associates (Botulinum Toxin Patent Portfolio) General Information
Description
A portfolio of botulinum toxin-related patents and patent applications. The botulinum toxin-related patents and patent applications consists novel formulations and diverse therapeutic indications, including inflammation, pain, neurological and mood/depression.
Contact Information
Corporate Office
- 1261 Furnace Brook Parkway
- Quincy, MA 02169
- United States
Corporate Office
- 1261 Furnace Brook Parkway
- Quincy, MA 02169
- United States
Botulinum Toxin Research Associates (Botulinum Toxin Patent Portfolio) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Botulinum Toxin Research Associates (Botulinum Toxin Patent Portfolio) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Botulinum Toxin Research Associates (Botulinum Toxin Patent Portfolio) FAQs
-
Where is Botulinum Toxin Research Associates (Botulinum Toxin Patent Portfolio) headquartered?
Botulinum Toxin Research Associates (Botulinum Toxin Patent Portfolio) is headquartered in Quincy, MA.
-
What industry is Botulinum Toxin Research Associates (Botulinum Toxin Patent Portfolio) in?
Botulinum Toxin Research Associates (Botulinum Toxin Patent Portfolio)’s primary industry is Buildings and Property.
-
Is Botulinum Toxin Research Associates (Botulinum Toxin Patent Portfolio) a private or public company?
Botulinum Toxin Research Associates (Botulinum Toxin Patent Portfolio) is a Private company.
-
What is the current valuation of Botulinum Toxin Research Associates (Botulinum Toxin Patent Portfolio)?
The current valuation of Botulinum Toxin Research Associates (Botulinum Toxin Patent Portfolio) is .
-
What is Botulinum Toxin Research Associates (Botulinum Toxin Patent Portfolio)’s current revenue?
The current revenue for Botulinum Toxin Research Associates (Botulinum Toxin Patent Portfolio) is .
-
Who are Botulinum Toxin Research Associates (Botulinum Toxin Patent Portfolio)’s investors?
Botulinum Toxin Research Associates has invested in Botulinum Toxin Research Associates (Botulinum Toxin Patent Portfolio).
-
When was Botulinum Toxin Research Associates (Botulinum Toxin Patent Portfolio) acquired?
Botulinum Toxin Research Associates (Botulinum Toxin Patent Portfolio) was acquired on 02-Jun-2016.
-
Who acquired Botulinum Toxin Research Associates (Botulinum Toxin Patent Portfolio)?
Botulinum Toxin Research Associates (Botulinum Toxin Patent Portfolio) was acquired by Revance Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process